Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[In vitro activity of twenty antibiotics against Rhodococcus equi].

D Clavé1, M Archambaud, R M Rouquet

  • 1Laboratoire de Bactériologie Virologie, CHU Rangueil, Toulouse.

Pathologie-Biologie
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profile of smoking dependency in hidradenitis suppurativa patients and smoking cessation outcomes.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Outbreak of trichinellosis in the Midi-Pyrénées region of France January - March 1998.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2017
Same author

Practical guidelines on e-cigarettes for practitioners and others health professionals. A French 2016 expert's statement.

Revue des maladies respiratoires·2017
Same author

Spawning behaviour of Allis shad Alosa alosa: new insights based on imaging sonar data.

Journal of fish biology·2016
Same author

CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals.

Mucosal immunology·2016
Same author

FDG-PET/CT findings during immune reconstitution in an HIV-1 patient infected with visceral leishmaniasis.

Infection·2013
Same journal

Pathologie-biologie·2020
Same journal

Antibacterial and antibiofilm activities of Laurus nobilis L. essential oil against Staphylococcus aureus strains associated with oral infections.

Pathologie-biologie·2015
Same journal

[Not Available].

Pathologie-biologie·2015
Same journal

Oxidative damage and histopathological changes in lung of rat chronically exposed to nicotine alone or associated to ethanol.

Pathologie-biologie·2015
Same journal

Biological diagnosis of diabetes mellitus.

Pathologie-biologie·2015
Same journal

Association of CagPAI integrity with severeness of Helicobacter pylori infection in patients with gastritis.

Pathologie-biologie·2015
See all related articles

This study assessed Rhodococcus equi antibiotic susceptibility in immunocompromised patients. Vancomycin, erythromycin, and rifampicin showed effectiveness, but resistance to rifampicin emerged over time.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Context:

  • Rhodococcus equi infections pose a significant threat to immunocompromised individuals, particularly those with HIV.
  • Understanding the in vitro antibiotic susceptibility patterns of R. equi is crucial for effective treatment strategies.

Purpose:

  • To evaluate the in vitro susceptibility of Rhodococcus equi strains to a panel of 20 antibiotics.
  • To identify effective antibiotics for treating R. equi infections in immunocompromised patients.
  • To investigate the development of antibiotic resistance in R. equi over time.

Summary:

  • Nine Rhodococcus equi strains, including isolates from HIV-positive patients, were tested against 20 antibiotics using agar dilution.
  • Imipenem and ceftriaxone demonstrated efficacy among beta-lactams. Vancomycin, teicoplanin, erythromycin, clarithromycin, rifampicin, gentamicin, and doxycycline exhibited the lowest minimum inhibitory concentrations (MICs).

Related Experiment Videos

  • A longitudinal analysis revealed the emergence of rifampicin resistance and a significant increase in imipenem MIC in strains from a single patient.

    • Impact:

    • Identifies key antibiotics for R. equi treatment, including vancomycin, erythromycin, and rifampicin.
    • Highlights the potential for rapid development of resistance to critical antibiotics like rifampicin and imipenem.
    • Informs clinical decision-making for managing R. equi infections in vulnerable populations.